Suvorexant for Preventing Alzheimer's Disease

Annals of NeurologyVolume 94, Issue 2 p. 414-414 Letters/Replies Suvorexant for Preventing Alzheimer's Disease Tomoyuki Kawada MD, Corresponding Author Tomoyuki Kawada MD [email protected] orcid.org/0000-0002-4426-4644 Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan Address correspondence to Dr Kawada, Department of Hygiene and Public Health, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo 113-8602, Japan. E-mail: [email protected]Search for more papers by this author Tomoyuki Kawada MD, Corresponding Author Tomoyuki Kawada MD [email protected] orcid.org/0000-0002-4426-4644 Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan Address correspondence to Dr Kawada, Department of Hygiene and Public Health, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo 113-8602, Japan. E-mail: [email protected]Search for more papers by this author First published: 27 June 2023 https://doi.org/10.1002/ana.26733Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Lucey BP, Liu H, Toedebusch CD, et al. Suvorexant acutely decreases tau phosphorylation and Aβ in the human CNS. Ann Neurol 2023; 94:27–40. 2Gao F, Liu T, Tuo M, Chi S. The role of orexin in Alzheimer disease: from sleep-wake disturbance to therapeutic target. Neurosci Lett 2021; 765:136247. 3Liguori C. Orexin and Alzheimer's disease. Curr Top Behav Neurosci 2017; 33: 305–322. 4Krystal AD. New developments in insomnia medications of relevance to mental health disorders. Psychiatr Clin North Am 2015; 38: 843–860. Volume94, Issue2August 2023Pages 414-414 ReferencesRelatedInformation